Mirati Therapeutics
MRTX
#3041
Rank
NZ$7.01 B
Marketcap
$100.05
Share price
0.00%
Change (1 day)
53.06%
Change (1 year)

Mirati Therapeutics (MRTX) Fails to deliver data

Key failure to deliver metrics for Mirati Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Mirati Therapeutics (MRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Mirati Therapeutics (MRTX) - since 2013

Volume in USD (price x number of shares), data since 2013

Mirati Therapeutics (MRTX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$6.73 M-49.4%
2023NZ$13.31 M-77.91%
2022NZ$60.27 M32.3%
2021NZ$45.55 M8.14%
2020NZ$42.12 M-28.18%
2019NZ$58.66 M69.74%
2018NZ$34.56 M124.1%
2017NZ$15.42 M184.96%
2016NZ$5.41 M6.38%
2015NZ$5.08 M38.88%
2014NZ$3.66 M32.7%
2013NZ$2.76 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
N/ANZ$4.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.03 MNZ$0.2 M Bahamas